Grand Pharmaceutical Group Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
2,703.00
2,369.00
2,560.00
2,671.00
2,011.00
1,241.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-420.00
-123.00
-892.00
-298.00
-227.00
-349.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,724.00
2,228.00
1,917.00
2,122.00
1,775.00
1,187.00
Cash Flow from Investing Activities
-2,031.00
-521.00
-2,577.00
-2,047.00
-2,051.00
-489.00
Cash Flow from Financing Activities
205.00
-1,685.00
464.00
-195.00
899.00
-497.00
Net Cash Inflow / Outflow
-31.00
-102.00
-314.00
-107.00
684.00
196.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
70.00
-124.00
-118.00
12.00
60.00
-3.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Grand Pharmaceutical Group Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
2703.643
886.58718359732
1,817.00
204.95%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-420.478
-92.8973830496187
-328.00
-352.63%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1724.165
1592.3334198318
132.00
8.28%
Cash Flow from Investing Activities
-2031.589
-1280.84675211872
-751.00
-58.61%
Cash Flow from Financing Activities
205.512
-414.461911378783
619.00
149.59%
Net Cash Inflow / Outflow
-31.354
-100.496707961732
69.00
68.80%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
70.558
2.47853570396504
68.00
2746.76%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -22.62% vs 16.23% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
1,724.16
2,228.28
-22.62%






